BioWorld

Jan. 15, 2008

View Archived Issues

Inspire Drops Bilastine, but all Eyes are on Denufosol

Inspire Pharmaceuticals Inc.'s decision to discontinue development of the oral antihistamine bilastine for allergic rhinitis was "no surprise" to Cowen & Co. analyst Ian Sanderson. (BioWorld Today) Read More

Compugen, Merck Sign GPCR Ligand Discovery Collaboration

Read More

Scaffolds Could Aid Transplants, Stem Cell Plasticity Research

Read More

FDA OKs Tysabri for Crohn's Disease

Read More

Panel Gives Cell Genesys OK to Continue Prostate Trial

Read More

Clinic Roundup

Read More

Financings Roundup

Read More

Other News To Note

Read More